iBio, Inc. — Director's Dealing 2026

Jan 30, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2026-01-28

Reporting Person: Duran Felipe (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-28	Stock Option (right to buy)	$2.23	A	179000	Acquired	2036-01-27	Common Stock (179000)	Direct

Footnotes

F1: These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, the remainder of the shares of common stock underlying the options granted will vest in equal quarterly installments over a 36-month period, provided that the reporting person remains employed by iBio, Inc.